MiniFlo for Advanced Dupuytren's Disease

Treatment of Stage III-IV Dupuytren's Disease With the MiniFlo External Fixator

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07505563

Enrollment

Registered

2026-04-01

Start date

2014-08-26

Completion date

2016-05-12

Last updated

2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dupuytren's Disease

Brief summary

The aim of this study is to investigate the potential use of the MiniFlo (CitiEffe) progressive distraction external fixator in the treatment of advanced Dupuytren's disease.

Interventions

DEVICEMiniFlo

MiniFlo distraction for the restoration of finger extension

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Dupuytren's disease * Age ≥ 18 years * Informed consent

Exclusion criteria

* Age \< 18 years * Pregnancy * Withdrawal of informed consent

Design outcomes

Primary

Measure	Time frame	Description
Extension deficit angle (degree)	12 months	Evaluation of extension deficit angle of fingers affected before and after the treatment. Min 0° (no deficit), Max 180° (high stage disease)

Secondary

Measure	Time frame	Description
Collagenase adverse effects	12 months	Assessment of potential adverse effects related to the use of collagenase
NRS scale	12 months	Evaluation of pain before and after the treatment. Min 0 (no pain), Max 10 (maximum pain)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026